Ensign Peak Advisors »

Kazia Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Kazia Therapeutics (KZIA) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Kazia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kazia Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kazia Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 111k 14.08

More positions owned by Ensign Peak Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Applied Materials (AMAT)

View all positions for Ensign Peak Advisors

Top funds holding Kazia Therapeutics

Boxer Capital Management
Putnam Fl Investment Management
Bleichroeder
Ikarian Capital
Dauntless Investment Group
Stonepine Capital Management
Susquehanna International
Point72 Asset Management
Ensign Peak Advisors
Citadel Advisors
Millennium Management
Jane Street
UBS Group
J. Goldman & Co
ADAR1 Capital Management

View all funds holding Kazia Therapeutics